Triasima Portfolio Management inc.

Position in NVS — Novartis AG

CIK 1938757 MONTREAL, A8

Position in NVS

as of Jun 30, 2026 · filed Jul 21, 2026 Compact

Position Value

$7,014,003

-$1,000,789 QoQ

Shares Held

44,755

-14.7% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.96%

of 13F equity value

Holder Rank

#215

of 1,603 holders

Holding Since

Sep 2023

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Triasima Portfolio Management inc. holds $24,778,845 across 3 Drug Manufacturers - General names. NVS ranks #2 (28.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	10,046	$12,049,474
2	NVS	Novartis AG This page	44,755	$7,014,003
3	GILD	Gilead Sciences, Inc.	45,238	$5,715,368

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$7,014,003	44,755	-14.7%	Shares	Sole	2026-07-21
2026-03-31	$8,014,792	52,470	+4.6%	Shares	Sole	2026-04-24
2025-12-31	$6,917,627	50,175	+185.8%	Shares	Sole	2026-02-02
2025-09-30	$2,251,253	17,555	+0.5%	Shares	Sole	2025-10-29
2025-06-30	$2,113,439	17,465	0.0%	Shares	Sole	2025-07-23
2025-03-31	$1,946,998	17,465	-14.8%	Shares	Sole	2025-05-02
2024-12-31	$1,994,660	20,498	-36.5%	Shares	Sole	2025-01-28
2024-09-30	$3,712,270	32,275	+160.3%	Shares	Sole	2024-11-12
2024-06-30	$1,320,104	12,400	-57.7%	Shares	Sole	2024-08-06
2024-03-31	$2,837,574	29,335	-0.6%	Shares	Sole	2024-04-26
2023-12-31	$2,979,119	29,505	+70.2%	Shares	Sole	2024-01-29
2023-09-30	$1,765,743	17,335	—	Shares	Sole	2023-11-14
No filing history on record for this holder in this stock.